MARKET

BDSX

BDSX

BIODESIX INC
NASDAQ
6.80
+0.08
+1.19%
After Hours: 6.64 -0.16 -2.35% 17:55 12/31 EST
OPEN
6.68
PREV CLOSE
6.72
HIGH
6.80
LOW
6.60
VOLUME
29.85K
TURNOVER
--
52 WEEK HIGH
31.20
52 WEEK LOW
3.436
MARKET CAP
54.10M
P/E (TTM)
-1.2692
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BDSX last week (1222-1226)?
Weekly Report · 12/29/2025 10:17
SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio
NASDAQ · 12/24/2025 18:48
Weekly Report: what happened at BDSX last week (1215-1219)?
Weekly Report · 12/22/2025 10:17
Cencora to Acquire OneOncology to Expand Community Oncology Solutions
NASDAQ · 12/19/2025 16:05
Weekly Report: what happened at BDSX last week (1208-1212)?
Weekly Report · 12/15/2025 10:24
Weekly Report: what happened at BDSX last week (1201-1205)?
Weekly Report · 12/08/2025 10:23
Biodesix To Present Data On Development Of New Ultra-Sensitive ESR1 Test For Initial Detection And Monitoring Of Mutations In HR+/HER2- Advanced Breast Cancers At SABCS
Benzinga · 12/03/2025 13:28
Biodesix To Present New Findings On Its On-Market Nodify Lung Tests, With Data Highlighting Importance Of Lung Nodule Risk Classification To Support Early Detection Of Lung Cancer, At 2025 NACLC
Benzinga · 12/03/2025 13:26
More
About BDSX
Biodesix, Inc. (Biodesix) is a diagnostic solutions and services company. The Company develops diagnostic tests addressing clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers over five Medicare-covered tests for patients with lung diseases. The blood based Nodify Lung Nodule Risk Assessment testing strategy, consisting of the Nodify XL2 and the Nodify CDT tests, evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the appropriate course of action. The blood based IQLung strategy for lung cancer patients integrates the GeneStrat targeted ddPCR test, the GeneStrat NGS test and the VeriStrat test to support treatment decisions across all stages of lung cancer. Biodesix also leverages the advanced Diagnostic Cortex artificial intelligence (AI) platform, to collaborate with biotechnology and pharmaceutical companies to solve complex diagnostic challenges in lung disease.

Webull offers Biodesix Inc stock information, including NASDAQ: BDSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDSX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDSX stock methods without spending real money on the virtual paper trading platform.